Anytime now they will all start dropping.
Just wait.
Just wait.
M
member 3289
Guest
Tell me you didn't get the joke without telling me you didn't get the joke.
M
member 3289
Guest
It's not.
M
member 3289
Guest
Hey @Lars (ADMlN) if you buy this he'll get arrested.
How funny is it going to be when they're like "Well, the vaccine doesn't actually stop you from getting cancer." ?
interestingengineering.com
BioNTech's mRNA Cancer Vaccine Has Started Phase 2 Clinical Trial
Colorectal cancer was chosen by BioNTech as an experimental vaccine target due to the disease's relatively high relapse rate.
lol
I had to unblock this tard to see the quote, he knows he's on ignore.
I guess he's competing for likes with the other rockstars in his basement.
I wonder if we can get Fauci to convince them their keyboards spread covid-19...
I guarantee they have applied hand sanitizer to their gloves within the last 30 seconds
Kind of rude bro
Sounds like a papa roach song
T
The Big Guy
Guest
How funny is it going to be when they're like "Well, the vaccine doesn't actually stop you from getting cancer." ?
BioNTech's mRNA Cancer Vaccine Has Started Phase 2 Clinical Trial
Colorectal cancer was chosen by BioNTech as an experimental vaccine target due to the disease's relatively high relapse rate.
Then they'll contract with the FDA to put mRNA in food.
Booster for breakfast, booster for lunch, booster for dinner.
From cradle to grave, everyone in a booster seat
Omicron coverage reveals how the establishment, media keep us scared
The official response to the Omicron variant provides a case study in the deliberate manufacture of fear.
nypost.com
Can't even spell the name right. Idiots.
But yes, it's us poisoning y'all. Also, the vaccine is just a distraction. Of course we put it in your food and drinks since nobody tests that shit. It's too late now.
Too bad the safe zone ctards are never gonna know the truth tho!
The US Army is set to announce it has developed a single vaccine that provides protection against all variants of Covid-19 and the SARS virus.
According to reports, scientists at the Walter Reed Army Institute of Research have been working on the vaccine for two years and they believe they've completed it. The official announcement could come within the next few weeks, Defense One first reported.
Researchers at the Institute began working on the vaccine, named SpFN, in early 2020 and set out to purposefully create a shot that would provide protection not just from the original Covid-19 strain, but all existing and potential variants, too.
They received positive results through animal testing this year and were approved to start human trials back in April. Dr. Kayvon Modjarrad, director of the Walter Reed Infectious Disease department, confirmed to Defense One that Phase I of trials against the Omicron and other variants were completed earlier this month.
So far, SpFN shows to provide broad protection against several Covid-19 and SARS variant.
Modjarrad said that the reason such a vaccine needed to be studied was due to the "accelerating emergences of human coronaviruses throughout the past two decades," and the multiple variants of SARS-CoV-2 (the virus that causes a Covid-19 infection) we've seen within the past two years alone.
"It's very exciting to get to this point for our entire time and I think for the entire Army as well," he added.
Phase I included testing the vaccine on people who had not been previously vaccinated against Covid-19 nor had they previously tested positive for the virus. The next phase will test SpFN on people who've been vaccinated or previously tested positive.
"With Omicron, there's no way really to escape this virus. You're not going to be able to avoid it. So I think pretty soon either the whole world will be vaccinated or have been infected," Modjarrad said.
According to reports, scientists at the Walter Reed Army Institute of Research have been working on the vaccine for two years and they believe they've completed it. The official announcement could come within the next few weeks, Defense One first reported.
Researchers at the Institute began working on the vaccine, named SpFN, in early 2020 and set out to purposefully create a shot that would provide protection not just from the original Covid-19 strain, but all existing and potential variants, too.
They received positive results through animal testing this year and were approved to start human trials back in April. Dr. Kayvon Modjarrad, director of the Walter Reed Infectious Disease department, confirmed to Defense One that Phase I of trials against the Omicron and other variants were completed earlier this month.
So far, SpFN shows to provide broad protection against several Covid-19 and SARS variant.
Modjarrad said that the reason such a vaccine needed to be studied was due to the "accelerating emergences of human coronaviruses throughout the past two decades," and the multiple variants of SARS-CoV-2 (the virus that causes a Covid-19 infection) we've seen within the past two years alone.
"It's very exciting to get to this point for our entire time and I think for the entire Army as well," he added.
Phase I included testing the vaccine on people who had not been previously vaccinated against Covid-19 nor had they previously tested positive for the virus. The next phase will test SpFN on people who've been vaccinated or previously tested positive.
"With Omicron, there's no way really to escape this virus. You're not going to be able to avoid it. So I think pretty soon either the whole world will be vaccinated or have been infected," Modjarrad said.
US Army Creates Single Vaccine Against All COVID & SARS Variants, Researchers Say
www.defenseone.com
US Army Creates Single Vaccine Against All COVID & SARS Variants, Researchers Say
Within weeks, Walter Reed researchers expect to announce that human trials show success against Omicron—and even future strains.
www.defenseone.com
lmao
M
member 3289
Guest
D
Deleted member 1
Guest
Endless amounts of chiropractors, and in this case a nurse educator, being used as appeals to authority. Always referencing the doctorate even when its the Doctor (in education!) from Oxford (ohio!).
Anyways here's the non peer reviewed abstract.
Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning
Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (pe
www.ahajournals.org
Here's the actual conclusion:
Taking that and running with it to predict clinical outcome is foolhardy and deceptive.
You can't take a short term inflammatory marker increase and then run a score on it if said inflammatory markers are transient since said scoring is based on inflammatory markers from natural long-term lifestyle processes. It's like running said scores on critically ill ICU patients, seeing they are terrible, and predicting everyone will have a heart attack next year, despite that person being in a transiently different physiologic state than they have been before and after.
Questions:
Are inflammatory markers elevating after ANY vaccine common?
Are the inflammatory markers elevated after COVID?
Population is 28 years old to 97 years old...what is the distribution of these inflammatory markers? Is it uniform? Or is it just the younger/older crowd.
None of this is answered because this is just an observational data point for a group already being followed. It's a useful data point to begin asking these additional questions. The guy in your twitter, like so many others making their money in this pandemic, is selling you fear and false expertise ironically while claiming every bit of that about people who actually do this research as their life's work.
